ReviewVascular health and risk management2019

Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives.

Antonis A Manolis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.